2027 Annual Scientific Meeting Preliminary Program

Select the dates below to expand the program schedule. Schedule information is subject to change. Additional faculty details to be added as invitations are accepted.

Last update: 10 June 2026. Please note that times are listed in the meeting time zone, Eastern Standard Time. 

Wednesday, 24 February 2027

Master Class – Interventional Radiology in Colorectal Cancer: From Disease Biology to Precision Locoregional Therapy

Designed to prepare interventional radiologists to function as disease-oriented specialists in colorectal cancer care, this preconference Master Class integrates contemporary oncology, surgery, and systemic therapy with advanced image-guided locoregional interventions, emphasizing multidisciplinary decision-making and precision treatment strategies to optimize patient outcomes. Participants will gain a structured, evidence-based framework for positioning interventional radiology within the modern colorectal cancer treatment paradigm, from localized disease to complex metastatic presentations and participate in a hands-on session.

Learn More

The RISE Forum: A Research, Innovation and Science Exchange

The RISE Forum is a comprehensive, expert-led program designed to equip interventional oncologists, scientists, and clinical investigators with the tools and knowledge to advance impactful research across the translational spectrum. From foundational laboratory platforms to clinical trial design and next-generation innovations, this immersive course spans the critical elements necessary for driving discovery and accelerating clinical progress in interventional oncology.

Learn More

Thursday, 25 February 2027

7:45 – 8:30 a.m.
Breakfast and Industry Symposium
8:30 – 8:45 a.m.
Break
8:45 – 10:15 a.m.
President’s Welcome and Wallace Lecture
10:15 – 10:30 a.m.
Break
10:30 – 11:30 a.m.
Controversies in the BCLC Update
 
  • Brief Introduction of Unsettled Issues in BCLC
  • Imaging Update — What the IR Needs to Know for Staging and Treatment Considerations
  • What are the Important Changes of the 2025 BCLC Update?
  • Discussion and Cases
10:30 – 11:20 a.m.
IO Essentials – MSK/Pain Palliation
 
  • Extraspinal Metastatic Bone Fixation and Augmentation
  • Basics of Spinal Augmentation and Ablation
  • Palliative Neurolysis for Cancer Pain
  • Thermoprotective Techniques and Anatomic Considerations
  • Cases
12:45 – 1:15 p.m.
Break
1:15 – 2:15 p.m.
Lunch Symposia
2:15 – 2:45 p.m.
Break
2:45 – 3:45 p.m.
IO Essentials: Lung
 
  • Patient Selection and Preparing for a Lung Tumor Board
  • Choosing the Right Tool: How to Select the Optimal Ablation Modality for Lung Tumors
  • RFA and MWA: How to Safely and Precisely Place, Optimize Applicator Number, Positioning, and Treatment Prescription
  • Cryoablation: How to Safely and Precisely Place, Optimize Applicator Number, Positioning, and Treatment Prescription
2:45 – 3:45 p.m.
GU Cancers: Current Challenges
 
  • Curative Ablation & RCC: SABR vs. Ablation: Where Are We?
  • Metastatic Renal Cancer: Combining LRTC and Systemic Therapy
  • Image-Guided Ablation for Prostate Cancer
  • Treating Functional Adrenal Disease
  • Discussion Q&A
2:45 – 5:00 p.m.
Ablation Planning, Confirmation & Guidance Workshop
 
  • Ablation Confirmation Software: Principles, Fundamentals, and Key Evidence
  • Limitations and Challenges of Ablation Confirmation Software
  • Stereotactic Ablation: From Planning to Treatment
  • Not Only the Liver: Preliminary Evidence in Lung and Kidney Ablation and Future Challenges
  • Hands On
3:45 – 5:00 p.m.
IO Essentials: Lung Hands-On and Cases
3:45 – 4:00 p.m.
Coffee Break
4:00 – 5:00 p.m.
Focus on Downstaging into MILAN
 
  • The Modern Allocation Landscape for HCC Transplantation
  • Neoadjuvant Immunotherapy Before Liver Transplant: Promise, Peril, and Practical Considerations
  • Are Downstaged Patients at Higher Risk for Post Transplant Recurrence?
  • Optimal Locoregional Therapy for Downstaging Patients Outside of MILAN
  • Discussion Q&A
4:00 – 5:00 p.m.
IO Essentials Exhibit Hall Walk With Faculty
5:00 – 5:15 p.m.
Break
5:15 – 6:15 p.m.
Liver Tumor Board
6:15 – 6:30 p.m.
Break
6:30 – 8:00 p.m.
Official Exhibit Hall Opening and SIO 2027 Welcome Reception

Friday, 26 February 2027

7:30 – 8:15 a.m.
Breakfast and Industry Symposium
8:15 – 8:45 a.m.
Break
8:30 – 9:15 a.m.
IO Essentials: Liver
 
  • Endpoint Analysis and Use of Confirmation Software
  • Choosing the Right Tool: How to Select the Optimal Ablation Modality for Liver Tumors
  • Complication Management and Avoidance in Liver Ablation
  • Case–Based Review of Ablative Therapies for Liver Interventions in Oncologic Patients
8:45 – 9:45 a.m.
Y90 Practical Considerations
 
  • Y90 Dosing Considerations
  • Technical Considerations of Using Y90 for Treating Large HCC Lesions
  • How to Deal with Complex Anatomy
  • Choosing Between Y90 and Chemoembolization
  • Y90 Complications and Management
  • Discussion Q&A
9:15 – 10:00 a.m.
IO Essentials: Kidney
 
  • Patient Selection and Functioning in a Multidisciplinary Team, Choosing Active Surveillance vs Treatment
  • RFA and MWA: How to Safely and Precisely Place, Optimize Applicator Number, Positioning, and Treatment Prescription in Renal Ablation
  • Cryoablation: How to Safely and Precisely Place, Optimize Applicator Number, Positioning, and Treatment Prescription in Renal Tumors
  • Complication and Complication Management
9:45 – 10:30 a.m.
Coffee Break in Exhibit Hall
10:30 – 11:30 a.m.
Loco–Regional Therapies for Lung Cancer
 
  • Guidelines & Current Evidence for Ablation in Primary Lung Cancer
  • Ablation vs SBRT vs. Proton Therapy
  • Lung Ablation: Risks and How to Prevent or Manage Them
  • Endobronchial Ablation for Lung Cancer
  • Bronchial Artery Embolization for Lung Metastastes
  • Discussion Q&A
10:30 – 11:30 a.m.
Discovery Theater: Late Breaking Abstracts & IO Research Awards
11:30 – 11:45 a.m.
Coffee Break in Exhibit Hall
11:45 a.m. – 12:45 p.m.
Liquid Embolics in IO
 
  • Portal Vein Embolization with Liquid Embolics
  • Staining of Liver Lesions to Optimize Ablation
  • RCC: Does Pre-embolization Help?
  • Pre Orthopedic Surgery Bone Metastases
  • Discussion Q&A
11:45 a.m. – 1:15 p.m.
IO Essentials: Liver and Kidney Hands On & Cases
12:45 p.m. – 1:15 p.m.
Industry Product Theater
1:15 – 2:15 p.m.
Lunch Symposia
2:15 – 2:45 p.m.
Industry Product Theater
2:45 – 3:45 p.m.
Intrahepatic Cholangiocarcinoma MD Treatment
 
  • Update on the Medical Treatment of Hepatic Cholangiocarcinoma
  • Status of Y90 for Curative and Downstaging Therapy in Intrahepatic Cholangiocarcinoma
  • Aggressive Multimodality Treatment for ICCA: Evidence
  • Defining Successful Downstaging in Cholangiocarcinoma: Surgical Criteria and Decision–Making
  • Discussion Q&A
2:45 – 6:15 p.m.
Y90 Dosimetry & Hands On Workshop
 
  • Introduction
  • Y90–Dosimetry Made Easy: What IRs Need to Know
  • Dosimetric Recommendations in Brief
  • Software Introduction Hands–On
  • Case 1: Radiation Segmentectomy
  • Case 2: Radiation Lobectomy
  • Case 3: Multifocal Biolobar Metastatic Disease or Cholangiocarcinoma
  • The Importance of Spheres’ Concentration and Distribution
  • Discussion Q&A
  • Conclusions
3:45 – 4:00 p.m.
Coffee Break in Exhibit Hall
4:00 – 5:00 p.m.
Critical Studies Update
 
  • CHOPIN – How Should We Treat Uveal Melanoma?
  • TRIBUTE – Where Are We?
  • ImmunoXXL
  • ROWAN – The Case for or Against Combination Immunoembolization
  • PRECICE – Implications for the Role of Breast Cryoablation
  • Discussion Q&A
  • EMERALD III [pipeline or y90]
  • [TIGER–PAC: Implications for Locoregional Approach in LAPC]
4:00 – 5:00 p.m.
Discovery Theater: Oral Abstracts
5:00 – 5:15 p.m.
Break
5:15 – 6:15 p.m.
Lung Tumor Board
6:15 – 6:30 p.m.
Coffee Break in Exhibit Hall
6:30 – 7:30 p.m.
Abstract Reception
8:00 – 10:00 p.m.
Friday Night Soirée

Saturday, 27 February 2027

7:15 – 9:45 a.m.
Pain Interventions and Palliation Workshop

Palliation of Malignant Pelvic Pain

 
  • Role of IR in Pain and Palliative Multidisciplinary Boards– An NCCN Guidelines and Best Practices Update
  • How I Do It– Nerve Blocks and Neurolysis for Malignant Pelvic Pain
  • Image Guided Management of Bone Metastasis to the Pelvis– Fixation, Ablation or Both
  • Non–Malignant Pain in Cancer Patients– What Can IR Offer?
  • Discussion Q&A

Primer to Starting a Pain Palliation Service Line

 
  • What Every IO Should Know When Developing an Oncologic Pain Palliation Service Line
  • Patient Assessment – Workup and Selection
  • Cryoneurolysis – What Happens to the Nerve, Expected and Unexpected
  • Implantable Pain Devices – Current State
  • Discussion Q&A

Pain Interventions and Palliation – Hands On

7:30 – 8:15 a.m.
Breakfast and Industry Symposium
8:15 – 8:45 a.m.
Break
8:30 – 9:20 a.m.
IO Essentials: Transarterial Therapies/HCC
 
  • Patient Selection and How to Work in a MDT Tumor Board
  • Multidisciplinary Treatment of HCC Patients
  • Transarterial Therapy in Metastatic Liver Disease
  • Current Role of Y90 and the Role of Combination Therapy in HCC
  • The Role of cTACE in HCC
8:45 – 9:45 a.m.
Multidisciplinary consensus on the treatment of NETLM
 
  • Multidisciplinary Consensus on the Treatment of NETLM: IR Perspective
  • Multidisciplinary Consensus on the Treatment of NETLM: Surgical Perspective
  • Optimal Systemic Treatment Sequencing
  • Embolotherapy Hierarchy
  • The Exception that Proves the Rule: When TARE Becomes First Choice
  • Discussion Q&A
9:20 – 10:15 a.m.
IO Essentials: Transarterial Therapies/HCC Hands–On and Cases
9:45 – 10:30 a.m.
Break in Hall
10:30 – 11:30 a.m.
Pre and Post–Liver Transplant Management in IO
 
  • Beyond Tumor Size: The New Generation of HCC Imaging Biomarkers or HCC Imaging Biomarkers: From LI–RADS to AI
  • Is Vascular Involvement by HCC a Never–Transplant Finding –Evidence?
  • Management of HCC with Vascular Involvement
  • Pre and Post–Transplant Management of Vascular Issues Affecting Transplant and Graft Survival
  • Biliary Complications After Curative Interventions
  • Discussion Q&A
10:30 – 11:30 a.m.
Discovery Theater: Scientific Oral Abstracts
11:30 – 11:45 a.m.
Coffee Break in Exhibit Hall
11:30 a.m. – 1:00 p.m.
IO Essentials: Tumor Board
11:45 a.m. – 12:45 p.m.
Soft Tissue Tumors: Desmoids, Sarcomas MDC
 
  • Locoregional Therapy for Sarcoma
  • Beads and Ice for Desmoid
  • Beyond the Abdomen: Treating Soft Tissue Mets
  • Ablation of Endometrioma
  • Discussion Q&A
12:45 – 1:15 p.m.
Industry Product Theater
1:15 – 2:15 p.m.
Lunch Symposia
2:15 – 2:45 p.m.
Industry Product Theater
2:45 – 3:45 p.m.
Engineering Better Responses to Cancer Immunotherapy
 
  • Immunotherapy Primer for IRs
  • Priming Endothelial Cells to Optimize Vascular Access of Tumors
  • Immune Monitoring for Image–Guided Treatments
  • Stromal Biomarkers as Predictors of Locoregional Response
  • Discussion Q&A
2:45 – 3:45 p.m.
Best Overall Abstracts
3:45 – 4:00 p.m.
Coffee Break in Exhibit Hall
4:00 – 5:00 p.m.
Grants Update Session
 
  • Understanding the Influence of Hepatocellular Carcinoma Tumor Immune Microenvironment on Response to Y–90 Radioembolization and Potential Combinations with Immune Checkpoint Inhibition
  • Spatial Proteogenomics for Prediction of Response in Combined Radioembolization and Immunotherapy of HCC
  • Optimized Locoregional Delivery of Immunotherapy in Liver Cancer Using Nanoparticle–Lipiodol Formulation Monitored by Molecular MRI
  • Development of a Next–Generation Drug Delivery System Utilizing Lipiodol in Combination with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
  • Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC
  • Discussion Q&A
4:00 – 5:00 p.m.
Non–Thermal Ablative Technologies
 
  • Electrochemotherapy
  • Current Evidence for Histotripsy in Liver
  • Pulsed Electric Field Ablation
  • Irreversible Electroporation (IRE)
  • Discussion Q&A
5:00 – 5:15 p.m.
Break
5:15 – 6:15 p.m.
Soft Tissue Tumor Board

Sunday, 28 February 2027

6:30 – 8:00 a.m.
Lymphatics Hands-On Workshop
 
  • Lymphatic Access Techniques
  • Imaging Techniques in Lymphangiography
  • Thoracic Duct Interventions
  • Lymphatic Leaks in the Pelvis After Oncologic Surgery
  • Advanced Lymphatic Interventions in Oncologic Patients
  • Case-based discussion
  • Hands On

Specialty Programming Opportunities

IO Essentials

IO Essentials is designed specifically for medical students, fellows, residents, and early career IO practitioners. Apply to join our cohort of IO Essentials scholars, and take advantage of content and networking opportunities developed just for you! IO Essentials programming will take place on Thursday, Friday, and Saturday.

Learn More

Annual Meeting Preconference Events

Wednesday, 24 February, 2027

Masterclass: Interventional Radiology in Colorectal Cancer: From Disease Biology to Precision Locoregional Therapy

Advance your expertise in colorectal cancer care through this immersive master class designed for interventional radiologists. Explore the full spectrum of disease management, from tumor biology and multidisciplinary treatment planning to advanced image-guided locoregional therapies. Through expert-led education, evidence-based discussions and a hands-on training session, you'll gain practical strategies for integrating IR into modern colorectal cancer care and optimizing outcomes for patients with both localized and metastatic disease.

Learn More

The RISE Forum: A Research, Innovation & Science Exchange  

SIO aims to advance the levels of evidence in interventional oncology (IO), supporting access to preclinical and clinical research efforts with this six-hour program. 

Learn More